COMP <GO>
LRCX vs ETN // FORWARD P/E MULTIPLE
Lam Research Corporation (NASDAQ) VS. Eaton Corporation PLC (NYSE) • 15-METRIC TALLY: LRCX 7
— ETN 7
▲ FORWARD P/E MULTIPLE LEADER: ETN
LAST: $254.39 (+0.23%) • MKT CAP: $317.78B
forward-pe
36.7x
LAST: $393.72 (+0.21%) • MKT CAP: $152.92B
forward-pe
34.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LRCX VS. ETN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LRCX | ETN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.50% | 37.60% | +12.90 | LRCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.50% | 14.50% | +11.00 | LRCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.8x | 27.8x | +7.00 | ETN | /valuation <GO> |
| Free Cash Flow Yield | 1.51% | 2.32% | -0.81 | ETN | /fcf-yield <GO> |
| Operating Margin | 35.30% | 18.20% | +17.10 | LRCX | /operating-margins <GO> |
| Net Profit Margin | 31.30% | 14.90% | +16.40 | LRCX | /net-margins <GO> |
| Revenue Growth (YoY) | 26.00% | 10.30% | +15.70 | LRCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.40% | 1.06% | -0.66 | ETN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 21.80 | 6.15 | +15.65 | LRCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | ETN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.7 | 47.6 | -5.90 | ETN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.29 | 1.37 | -0.08 | ETN | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 36.7x | 34.8x | +1.90 | ETN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $317.78B | $152.92B | $164.86B | LRCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LRCX REV | ETN REV | LRCX GROSS % | ETN GROSS % | LRCX FCF | ETN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.23B | $27.45B | 50.5% | 37.6% | $4.81B | $3.55B |
| FY 2024 | $18.44B | $24.88B | 48.7% | 38.2% | $5.34B | $3.52B |
| FY 2023 | — | $23.20B | — | — | — | $2.58B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LRCX // BETA 1.29
ETN // BETA 1.37